SpringerLink
Log in

Inflammatory bowel disease: the problems of dysplasia and surveillance

  • Case Report
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Patients with ulcerative colitis and colonic Crohn’s disease are at an increased risk of develo** colorectal malignancy. The reporting of such cases in the literature has led to the identification of a number of risk factors for the development of mucosal dysplasia and cancer. The diagnosis of dysplasia and the subsequent management, however, are not without controversy, as is the practice of surveillance colonoscopy that is commonly performed in an attempt to reduce the risk of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Brazil)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Crohn B, Rosenberg H (1925) The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci 170:220–228

    Google Scholar 

  2. Rutter MD, Saunders BP, Wilkinson KH et al (2006) Thirty year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130:1030–1038

    PubMed  Google Scholar 

  3. Eaden JA, Abrams KA, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526–535

    PubMed  CAS  Google Scholar 

  4. Itzkowitz SH, Present DH (2005) Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11:314–321

    PubMed  Google Scholar 

  5. Rubin DT, Kavitt RT (2006) Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin N Am 35:581–604

    Google Scholar 

  6. de Dombal FT, Watts JM, Watkinson G, Goligher JC (1966) Local complications of ulcerative colitis: stricture, pseudopolyposis and carcinoma of the colon and rectum. Br Med J 1:1442–1447

    PubMed  Google Scholar 

  7. MacDermott RP (1985) Review of clinical aspects of the colon in patients with ulcerative colitis. Dig Dis Sci 30:114S–118S

    PubMed  CAS  Google Scholar 

  8. Gyde SN, Prior P, Allan RN et al (1988) Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 29:206–217

    PubMed  CAS  Google Scholar 

  9. BroomÈ U, Lindberg G, Lofberg R (1992) Primary sclerosing cholangitis in ulcerative colitis — a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 102:1877–1880

    PubMed  Google Scholar 

  10. Jayaram H, Satsangi J, Chapman RW (2001) Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut 48:430–434

    PubMed  CAS  Google Scholar 

  11. Shetty K, Rybicki L, Brzezinski, A, Carey WD, Lashner BA (1999) The risk of cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 94:1643–1649

    PubMed  CAS  Google Scholar 

  12. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56:48–54

    PubMed  Google Scholar 

  13. Askling J, Dickman PW, Karlen P et al (2001) Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120:1356–1362

    PubMed  CAS  Google Scholar 

  14. Nuako KW, Ahlquist DA, Mahoney DW, Schaid DJ, Siems DM, Lindor NM. (1998) Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case control study. Gastroenterology 115:1079–1083

    Article  PubMed  CAS  Google Scholar 

  15. Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 323:1228–1233

    Article  PubMed  CAS  Google Scholar 

  16. Rutter MD, Saunders BP, Wilkinson KH et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451–459

    PubMed  Google Scholar 

  17. Rutter M, Saunders B, Wilkinson KH et al (2004) Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 53:1813–1816

    PubMed  CAS  Google Scholar 

  18. Warren S, Sommers SC (1948) Cicatrizing enteritis as a pathological entity. Am J Pathol 24:475–501

    PubMed  CAS  Google Scholar 

  19. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH (1981) A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 48:2742–2745

    PubMed  CAS  Google Scholar 

  20. Gyde SN, Prior P, MacCartney JC, Thompson H, Waterhouse JA, Allan RN (1980) Malignancy in Crohn’s disease. Gut 21:1024–1029

    PubMed  CAS  Google Scholar 

  21. Ekbom A, Helmick C, Zack M, Adami HO (1990) Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 336:357–359

    PubMed  CAS  Google Scholar 

  22. Gillen CD, Andrews HA, Prior P, Allan RN (1994) Crohn’s disease and colorectal cancer. Gut 35:651–656

    PubMed  CAS  Google Scholar 

  23. Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 23:1097–1104

    PubMed  CAS  Google Scholar 

  24. Friedman S (2006) Cancer in Crohn’s disease. Gastroenterol Clin N Am 35:621–639

    Google Scholar 

  25. Ribeiro MB, Greenstein AJ, Sachar DB et al (1996) Colorectal adenocarcinoma in Crohn’s disease. Ann Surg 223:186–193

    PubMed  CAS  Google Scholar 

  26. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF (1973) Crohn’s disease and cancer. N Engl J Med 289:1099–1102

    Article  PubMed  CAS  Google Scholar 

  27. Yamazaki Y, Ribeiro MB, Sachar DB, Aufses AH, Greenstein AJ (1991) Malignant colorectal strictures in Crohn’s disease. Am J Gastroenterol 86:882–885

    PubMed  CAS  Google Scholar 

  28. Stahl TJ, Schoetz DJ, Roberts PL et al (1992) Crohn’s disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum 35:850–856

    PubMed  CAS  Google Scholar 

  29. Greenstein AJ, Sachar DB, Pucillo A et al (1978) Cancer in Crohn’s disease after diversionary surgery: a report of seven carcinomas occurring in excluded bowel. Am J Surg 135:86–90

    PubMed  CAS  Google Scholar 

  30. Itzkowitz SH, Yio X (2004) Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Gastrointest Liver Physiol 287:G7–G17

    CAS  Google Scholar 

  31. Burmer GC, Rabinovitch PS, Haggitt RC et al (1992) Neoplastic progression in ulcerative colitis: histology, DNA content and loss of p53 allele. Gastroenterology 103:1602–1610

    PubMed  CAS  Google Scholar 

  32. Hoque AT, Hahn SA, Schutte M, Kern SE (1997) DPC4 gene mutation in colitis associated neoplasia. Gut 40:120–122

    PubMed  CAS  Google Scholar 

  33. Umetani N, Sasaki S, Watanabe T et al (1999) Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability. Jpn J Cancer Res 90:1081–1087

    PubMed  CAS  Google Scholar 

  34. Schulmann K, Mori Y, Croog V et al (2005) Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. Gastroenterology 129:74–85

    PubMed  CAS  Google Scholar 

  35. Herszenyi L, Miheller P, Tulassay Z (2007) Carcinogenesis in inflammatory bowel disease. Dig Dis 25:267–269

    PubMed  Google Scholar 

  36. Riddell RH, Goldman H, Ransohoff DF et al (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14:931–968

    PubMed  CAS  Google Scholar 

  37. Warren S, Sommers SC (1949) Pathogenesis of ulcerative colitis. Am J Pathol 25:657–679

    PubMed  CAS  Google Scholar 

  38. Collins RH, Feldman M, Fordman JS (1987) Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: a critical review. N Engl J Med 316:1654–1658

    Article  PubMed  Google Scholar 

  39. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH (1994) Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107:934–944

    PubMed  CAS  Google Scholar 

  40. Melville DM, Jass JR, Morson BC et al (1989) Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 20:1008–1014

    PubMed  CAS  Google Scholar 

  41. Dixon NF, Brown LJR, Gilmour HM et al (1988) Observer variation in the assessment of dysplasia of ulcerative colitis. Histopathology 13:385–398

    PubMed  CAS  Google Scholar 

  42. Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel disease. Gastroenterology 126:1634–1648

    PubMed  Google Scholar 

  43. Stange EF, Travis SPL, Vermeire S et al for the European Crohn’s and Colitis Organisation (ECCO) (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55:i1–i15

    PubMed  Google Scholar 

  44. Rubin CE, Haggitt RC, Burmer GC et al (1992) DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 103:1611–1620

    PubMed  CAS  Google Scholar 

  45. Kornbluth A, Sachar DB (2004) Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 99:1371–1385

    PubMed  Google Scholar 

  46. Eaden JA, Mayberry JF (2002) Guidelines for the screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51:10–12

    Google Scholar 

  47. Bernstein CN, Weinstein WM, Levine DS, Shanahan F (1995) Physicians’ perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 90:2106–2114

    PubMed  CAS  Google Scholar 

  48. Eaden JA, Ward BA, Mayberry JF (2000) How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 51:123–128

    PubMed  CAS  Google Scholar 

  49. Linberg B, Perrson B, Veress B, Ingel-Sundberg H, Granqvist S (1996) Twenty years’ colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand J Gastroenterol 31:1195–1204

    Google Scholar 

  50. Ullman TA, Loftus EV Jr, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ (2002) The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 97:922–927

    PubMed  Google Scholar 

  51. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz SH (2003) Progression of flat low grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125:1311–1319

    PubMed  Google Scholar 

  52. Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343:71–74

    PubMed  CAS  Google Scholar 

  53. Taylor BA, Pemberton JH, Carpenter HA et al (1992) Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 35:950–956

    PubMed  CAS  Google Scholar 

  54. Lim CH, Dixon MF, Vail A, Forman D, Lynch DA, Axon AT (2003) Ten-year follow-up of ulcerative colitis patients with and without low grade dysplasia. Gut 52:1127–1132

    PubMed  CAS  Google Scholar 

  55. Befrits R, Ljung T, Jaramillo E, Rubio C (2002) Low grade dysplasia in extensive long standing inflammatory bowel disease: a follow up study. Dis Colon Rectum 45:615–620

    PubMed  CAS  Google Scholar 

  56. Rodriguez SA, Collins JM, Knigge KL, Eisen GM (2007) Surveillance and management of dysplasia in ulcerative colitis. Gastrointest Endosc 65:432–439

    PubMed  Google Scholar 

  57. Blackstone MO, Riddell RH, Rogers BH. Levin B (1981) Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 80:366–374

    PubMed  CAS  Google Scholar 

  58. Ludeman L, Shephard NA (2006) Problem areas in the pathology of chronic inflammatory bowel disease. Curr Diagn Pathol 12:248–260

    Google Scholar 

  59. Goldblum JR (2003) The histologic diagnosis of dysplasia, dysplasia associated lesion or mass, and adenoma. A pathologists’ perspective. J Clin Gastroenterol 36:S63–S69

    PubMed  Google Scholar 

  60. Torres C, Antonioli D, Odze RD (1998) Polypoid dysplasia and adenomas in inflammatory bowel disease; a clinical, pathologic and follow-up study of 89 polyps from 50 patients. Am J Surg Pathol 22:275–284

    PubMed  CAS  Google Scholar 

  61. Rutter CE, Saunders DP, Wilkinson KH, Kamm MA, Williams CB, Forbes A (2004) Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 103:1611–1620

    Google Scholar 

  62. Odze RD, Farraye FA, Hecht JL, Hornick JL (2004) Longterm follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2:534–541

    PubMed  Google Scholar 

  63. Rubin PH, Friedman S, Harpaz N et al (1999) Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 117:1295–1300

    PubMed  CAS  Google Scholar 

  64. Farraye FA, Waye JD, Moscandrew M, Heeren TC, Odze RD (2007) Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an internet based study. Gastrointest Endosc 66:519–529

    PubMed  Google Scholar 

  65. Hurlstone DP, Sanders DS, Atkinson R et al (2007) Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic paradigm? Gut 56:838–846

    PubMed  Google Scholar 

  66. Morson BC, Pang LSC (1967) Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 8:423–434

    PubMed  CAS  Google Scholar 

  67. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB (1983) Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet 2:149–152

    PubMed  CAS  Google Scholar 

  68. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A (1990) Colonoscopic surveillance in long standing total ulcerative colitis — A 15-year follow up study. Gastroenterology 99:1021–1031

    PubMed  CAS  Google Scholar 

  69. Rozen P, Baratz M, Ferer F, Gilat T (1995) Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 108:1361–1370

    PubMed  CAS  Google Scholar 

  70. Lashner BA, Kane SV, Hanauer SB (1990) Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 85:1083–1087

    PubMed  CAS  Google Scholar 

  71. Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC (1993) Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105:418–424

    PubMed  CAS  Google Scholar 

  72. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A (1998) Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42:711–714

    Article  PubMed  CAS  Google Scholar 

  73. Collins PD, Mpofu C, Watson AJ, Rhodes JM (2006) Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 19:CD000279

    Google Scholar 

  74. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH (2001) Screening and surveillance colonoscopy on chronic Crohn’s colitis. Gastroenterology 120:820–826

    PubMed  CAS  Google Scholar 

  75. Choi PM, Zelig MP (1994) Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35:950–954

    PubMed  CAS  Google Scholar 

  76. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RA (1994) Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35:1590–1592

    PubMed  CAS  Google Scholar 

  77. Bernstein CN, Blanchard JF, Kliewer E, Wadja A (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854–862

    PubMed  CAS  Google Scholar 

  78. Svreck M, Cosnes J, Beaugerie L et al (2007) Colorectal neoplasia in Crohn’s colitis: a retrospective comparative study with ulcerative colitis. Histopathology 50:574–583

    Google Scholar 

  79. Sacchar DB (1994) Cancer in Crohn’s disease: dispelling the myths. Gut 35:1507–1508

    Google Scholar 

  80. Parks AG, Nicholls RJ (1978) Proctocolectomy without ileostomy for ulcerative colitis. Br Med J 2:85–88

    PubMed  CAS  Google Scholar 

  81. Lovegrove RE, Constantinides VA, Heriot AG et al (2006) A comparison of hand-sewn versus stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy. Ann Surg 244:18–26

    PubMed  Google Scholar 

  82. Fazio VW, Ziv Y, Church JM et al (1995) Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 222:120–127

    PubMed  CAS  Google Scholar 

  83. Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH (1998) J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 85:800–803

    PubMed  CAS  Google Scholar 

  84. Lofberg R, Liljeqvist L, Lindquist K, Veress B, Reinholt FP, Tribukait B (1991) Dysplasia and DNA aneuploidy in a pelvic pouch. Report of a case. Dis Colon Rectum 34:280–283

    PubMed  CAS  Google Scholar 

  85. Herline AJ, Meisinger LL, Rusin LC et al (2003) Is routine pouch surveillance for dysplasia indicated for ileoanal pouches? Dis Colon Rectum 46:156–159

    PubMed  Google Scholar 

  86. Borjesson L, Willen R, Haboubi NY, Duff SE, Hulten L (2004) The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study. Colorectal Dis 6:494–498

    PubMed  CAS  Google Scholar 

  87. Thompson-Fawcett MW, Marcus V, Redston M, Cohen Z, McLeod RS (2001) Risk of dysplasia in long term ileal pouches and pouches with chronic pouchitis. Gastroenterology 12:275–281

    Google Scholar 

  88. Veress B, Reinholt FP, Lindquist K, Lofberg R, Liljeqvist L (1995) Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a sub-group of patients. Gastroenterology 109:1090–1097

    PubMed  CAS  Google Scholar 

  89. Gullberg K, Stahlberg D, Liljeqvist L et al (1997) Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology 112: 1487–1492

    PubMed  CAS  Google Scholar 

  90. Remzi FH, Fazio VW, Delaney CP et al (2003) Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of prospective evaluation after a minimum of ten years. Dis Colon Rectum 46:6–13

    PubMed  Google Scholar 

  91. Tsunoda A, Talbot IC, Nicholls RJ (1990) Incidence of dysplasia in the anorectal mucosa in patients having restorative proctocolectomy. Br J Surg 77: 506–508

    PubMed  CAS  Google Scholar 

  92. Coull DB, Lee FD, Anderson JH, McKee RF, Finlay IG, Dunlop MG (2006) Long-term cancer risk of the anorectal cuff following restorative proctocolectomy assessed by p53 expression and cuff dysplasia. Colorectal Disease 9:321–327

    Google Scholar 

  93. Das P, Johnson MW, Tekkis PP, Nicholls RJ (2007) Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 9:15–27

    PubMed  CAS  Google Scholar 

  94. Carter MJ, Lobo AJ, Travis SP (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53:V1–V16

    PubMed  Google Scholar 

  95. Chambers WM, Warren BF, Jewell DP, Mortensen NJ (2005) Cancer surveillance in ulcerative colitis. Br J Surg 92:928–936

    PubMed  CAS  Google Scholar 

  96. Rosenstock E, Farmer RG, Petras R, Sivak MV Jr, Rankin GB, Sullivan BH. (1985) Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 89:1342–1346

    PubMed  CAS  Google Scholar 

  97. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB (1990) Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 31: 800–806

    PubMed  CAS  Google Scholar 

  98. Provenzale D, Wong JB, Onken JE, Lipscomb J (1998) Performing a cost effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol 93:872–880

    PubMed  CAS  Google Scholar 

  99. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC (2004) Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 53:256–260

    PubMed  CAS  Google Scholar 

  100. Kiesslich R, Fritsch J, Holtmann M et al (2003) Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124: 880–888

    PubMed  Google Scholar 

  101. Chen R, Rabinovitch PS, Crispin DA et al (2003) DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol 162:665–672

    PubMed  CAS  Google Scholar 

  102. Selaru FM, Xu Y, Yin J et al (2002) Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology 122:606–613

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery Wythenshawe Hospital, South Manchester University Hospitals NHS Trust, Wythenshawe, Manchester, UK

    P. J. Mitchell

  2. Department of Surgical Pathology, Trafford Healthcare NHS Trust, Davyhulme, Manchester, UK

    E. Salmo & N. Y. Haboubi

Authors
  1. P. J. Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Salmo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Y. Haboubi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Y. Haboubi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitchell, P.J., Salmo, E. & Haboubi, N.Y. Inflammatory bowel disease: the problems of dysplasia and surveillance. Tech Coloproctol 11, 299–309 (2007). https://doi.org/10.1007/s10151-007-0386-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-007-0386-2

Key words

Search

Navigation